Sunday, January 16, 2022 9:53:37 AM
American Society of Cancet Oncologists' (ASCO's) symposiums introduce and update therapeutic developments.
We've been introduced and progress noted in admittedly small clinical trials..Trial data for both our Sarcoma and Pancreatic are due.
______________________
Here's the MPS drug regimine concurrent with SM-88
trial(s) ,,,, designed to evaluate the safety and efficacy of SM-88 used with MPS (methoxsalen (1), phenytoin(2) and sirolimus) in pancreatic cancer and will measure multiple endpoints, including overall survival, progression free survival, relevant biomarkers, quality of life, safety, and overall response rate.
…..(1) Methoxsalen - used with UV light on skin to prevent severe psoriasis
…..(2) Phenytoin - Anti-seizure and –convulsant used to control certain type of seizures, and to treat and prevent seizures that may begin during or after surgery to the brain or nervous system. Phenytoin is in a class of medications called anticonvulsants. It works by decreasing abnormal electrical activity in the brain
….(3) Sirolimus - immuno suppressants
O______________________
This year's ASCO shindig Annie excerpt
TYME Technologies, Inc. (Nasdaq: …... Oral SM-88 plus MPS, an effective yet less toxic treatment option in second-line advanced pancreatic cancer.
Final phase II/III study results, has been accepted for poster presentation at the 2022 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium, January 20 – 22, 2022, in San Francisco, CA.
________________________Excerpts from Last Year's cocktail party :)
Journal of Clinical Oncology - published online before print January 22, 2021
Phase II/III Study of SM-88 in Patients with Metastatic Pancreatic Cancer.
Randomized and evaluable subjects (n=38) included mean age 65y (45-86);
BMI 24.6 (18.8-38.7); female 39.5%; White 76.3%. Of treated subjects 65.8% (25/38) had 166 AEs, with 25.7% (26/101) being at least possibly SM-88-related
______________<_________
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM